HomepageCRL • NYSE
add
Charles River Laboratories
$ 219,61
Na sluitingstijd:(0,00%)0,00
$ 219,61
Gesloten: 23 jan, 17:07:01 GMT-5 · USD · NYSE · Disclaimer
Vorige slotkoers
$ 224,03
Dag-range
$ 217,57 - $ 223,20
Jaar-range
$ 91,86 - $ 228,88
Beurswaarde
10,81 mld. USD
Gem. volume
699,77K
Koers/winst
-
Dividendrendement
-
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,00 mld. | -0,49% |
Bedrijfskosten | 201,05 mln. | -8,50% |
Netto inkomsten | 54,42 mln. | -21,87% |
Netto winstmarge | 5,42 | -21,45% |
Winst per aandeel | 2,43 | -6,18% |
EBITDA | 165,25 mln. | -30,05% |
Effectief belastingtarief | 36,29% | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 207,10 mln. | -1,46% |
Totale activa | 7,51 mld. | -6,12% |
Totale passiva | 4,06 mld. | -2,71% |
Totaal aandelenvermogen | 3,45 mld. | — |
Uitstaande aandelen | 49,22 mln. | — |
Koers-boekwaardeverhouding | 3,24 | — |
Rendement op activa | 5,01% | — |
Rendement op kapitaal | 6,16% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 54,42 mln. | -21,87% |
Operationele kasstroom | 213,83 mln. | -15,08% |
Kasstroom uit beleggingen | -33,70 mln. | -58,02% |
Kasstroom uit financiering | -152,62 mln. | 26,46% |
Nettomutatie in liquide middelen | 24,48 mln. | -20,09% |
Vrije kasstroom | 60,91 mln. | -72,72% |
Over
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Opgericht
1947
Hoofdvestiging
Website
Werknemers
19.400